$CVRX Income Statement | Understand Stock

$CVRX

$1.45 +$0.03 (2.11%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Cost of goods sold
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
Loss from operations
Interest expense
Other income, net
Loss before income taxes
Benefit (provision) for income taxes
Net loss
Cumulative translation adjustment
Comprehensive loss
Net loss per share, basic and diluted
Weighted-average common shares used to compute net loss per share, basic and diluted
Net loss per share, basic
Net loss per share, diluted
Weighted-average common shares used to compute net loss per share, basic
Weighted-average common shares used to compute net loss per share, diluted

Comments